ZA959008B - Competitive progesterone antagonists for demand-oriented female birth control - Google Patents

Competitive progesterone antagonists for demand-oriented female birth control

Info

Publication number
ZA959008B
ZA959008B ZA959008A ZA959008A ZA959008B ZA 959008 B ZA959008 B ZA 959008B ZA 959008 A ZA959008 A ZA 959008A ZA 959008 A ZA959008 A ZA 959008A ZA 959008 B ZA959008 B ZA 959008B
Authority
ZA
South Africa
Prior art keywords
demand
birth control
progesterone antagonists
competitive progesterone
female birth
Prior art date
Application number
ZA959008A
Other languages
English (en)
Inventor
Kristoff Chwalisz
Klaus Stoeckemann
Karin Schmidt-Gollwitzer
Walter Klemann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA959008B publication Critical patent/ZA959008B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
ZA959008A 1994-10-24 1995-10-24 Competitive progesterone antagonists for demand-oriented female birth control ZA959008B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4438820 1994-10-24

Publications (1)

Publication Number Publication Date
ZA959008B true ZA959008B (en) 1996-09-16

Family

ID=6532105

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959008A ZA959008B (en) 1994-10-24 1995-10-24 Competitive progesterone antagonists for demand-oriented female birth control

Country Status (25)

Country Link
US (1) US6143754A (xx)
EP (1) EP0787002B1 (xx)
JP (1) JPH10507461A (xx)
KR (1) KR970706827A (xx)
CN (1) CN1211087C (xx)
AT (1) ATE347894T1 (xx)
AU (1) AU707235B2 (xx)
BG (1) BG62877B1 (xx)
BR (1) BR9509478A (xx)
CA (1) CA2203541A1 (xx)
CZ (1) CZ290690B6 (xx)
DE (1) DE59511071D1 (xx)
DK (1) DK0787002T3 (xx)
ES (1) ES2279515T3 (xx)
FI (1) FI971742A0 (xx)
HU (1) HU226566B1 (xx)
IL (1) IL115738A (xx)
NO (1) NO314437B1 (xx)
NZ (1) NZ295365A (xx)
PL (1) PL319869A1 (xx)
PT (1) PT787002E (xx)
RO (1) RO120606B1 (xx)
SK (1) SK283662B6 (xx)
WO (1) WO1996012494A1 (xx)
ZA (1) ZA959008B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19745085A1 (de) * 1997-10-11 1999-04-15 Jenapharm Gmbh 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EE200200103A (et) * 1999-08-31 2003-04-15 Jenapharm Gmbh & Co. Kg Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina
EE200200102A (et) * 1999-08-31 2003-04-15 Jenapharm Gmbh & Co. Kg Mesoprogestiinid (progesterooniretseptori modulaatorid) hormoonasendusravi (HAR) kompositsioonide komponendina
US7629334B1 (en) 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
JP2011507853A (ja) * 2007-12-20 2011-03-10 テバ ウィメンズ ヘルス インコーポレイテッド 緊急避妊のための投与量レジメンならびに薬学的組成物およびパッケージ
ES2574999T3 (es) * 2009-04-14 2016-06-23 Laboratoire Hra-Pharma Método para la contracepción a demanda usando levonorgestrel o norgestrel
NZ615430A (en) 2009-04-14 2014-06-27 Laboratoire Hra-Pharma Method for on-demand contraception
MX2015016121A (es) 2013-05-23 2016-03-31 Bayer Pharma AG Composicion farmaceutica, su uso y regimen de administracion para contracepcion a demanda.
EP3247362A4 (en) 2014-11-17 2018-10-10 Context Biopharma Inc. Onapristone extended-release compositions and methods
AU2016326657B2 (en) 2015-09-25 2019-10-24 Context Biopharma, Inc. Methods of making onapristone intermediates
KR20180113988A (ko) * 2015-12-15 2018-10-17 컨텍스트 바이오파마 인코포레이티드 비정질 오나프리스톤 조성물 및 그 제조방법
WO2018102369A1 (en) 2016-11-30 2018-06-07 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439913A (en) * 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein

Also Published As

Publication number Publication date
EP0787002B1 (de) 2006-12-13
HUT77518A (hu) 1998-05-28
EP0787002A1 (de) 1997-08-06
US6143754A (en) 2000-11-07
SK51897A3 (en) 1997-09-10
NZ295365A (en) 1999-07-29
FI971742A (fi) 1997-04-23
CN1211087C (zh) 2005-07-20
NO971869D0 (no) 1997-04-23
BR9509478A (pt) 1997-09-30
HU226566B1 (en) 2009-04-28
IL115738A0 (en) 1996-01-19
BG101427A (en) 1997-11-28
CN1161649A (zh) 1997-10-08
IL115738A (en) 2002-05-23
SK283662B6 (sk) 2003-11-04
DK0787002T3 (da) 2007-04-10
CZ118097A3 (en) 1997-07-16
DE59511071D1 (de) 2007-01-25
CA2203541A1 (en) 1996-05-02
RO120606B1 (ro) 2006-05-30
KR970706827A (ko) 1997-12-01
AU707235B2 (en) 1999-07-08
NO971869L (no) 1997-04-23
JPH10507461A (ja) 1998-07-21
ES2279515T3 (es) 2007-08-16
WO1996012494A1 (de) 1996-05-02
BG62877B1 (bg) 2000-10-31
NO314437B1 (no) 2003-03-24
FI971742A0 (fi) 1997-04-23
PT787002E (pt) 2007-03-30
ATE347894T1 (de) 2007-01-15
MX9703018A (es) 1997-10-31
PL319869A1 (en) 1997-09-01
AU3869695A (en) 1996-05-15
CZ290690B6 (cs) 2002-09-11

Similar Documents

Publication Publication Date Title
ZA959008B (en) Competitive progesterone antagonists for demand-oriented female birth control
ATE217192T1 (de) Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen
EP0402950A3 (en) Treatment of postmenopausal disorders
GB9416442D0 (en) Therapeutic heterocycles
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
HU9602668D0 (en) Progesterone antagonists useful preparing medicaments for treating dysfunctional uterine bleeding
MX9702162A (es) Procedimiento para hacer unidades de dosis mediante granulacion en humedo.
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
IL109076A0 (en) Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them
EP0301850A3 (en) Lhrh antagonist analogs and 19-nor-progestational steroids for therapy
HUP9900313A1 (hu) Antiösztrogének alkalmazása hím nemzőképesség szabályozására
Asbjorn et al. Low dose of gestagen as a contraceptive method. A clinical trial
Robertson A study of women on the progestogen only pill
UA23363A (uk) Спосіб лікування запальних процесів придатків матки
UA23364A (uk) Спосіб лікування гострого ендометриту
MX9704742A (es) Compuestos con propiedades antagonistas de progesterona y anti-estrogeno para su uso combinado en la anticoncepcion femenina.
GR890100353A (el) Αναλισκομενος διανεμητης μιας δοσεως δια κολπικες κρεμες.